The IGSP is a research institute where clinical trials are an important part of translating research into clinical practice. Although many of our scientists perform research involving patients, we are not a health-care facility. The IGSP does not offer treatment. All clinical trials that include our research are done together with Duke University Medical Center or the Duke Comprehensive Cancer Center. Always discuss any questions about your treatment with your cancer doctor or surgeon.
If you have questions about genomics, cancer or NSCLC research at the IGSP, call 919-668-6498
To find clinical trials at a hospital near you or to learn more about cancer, please call the National Cancer Institute hotline: 1-800-4-CANCER.
Useful Links
- American Cancer Society
- Cancer and Leukemia Group B
- ClinicalTrials.gov
- Clinical Trials at Duke
- Duke Comprehensive Cancer Center
- The Cancer Genome Atlas
- The National Cancer Institute
Scientific Publications from IGSP Scientists
Potti et.al. (2006) A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. New England Journal of Medicine 355: 570
Potti et.al. (2006) Genomic Signatures to Guide the Use of Chemotherapeutics. Nature Medicine 12: 1294
Hsu et.al. (2007) Pharmacogenomic Strategies Provide a Rational Approach to the Treatment of Cisplatin-Resistant Patients Advanced Cancer. Journal of Clinical Oncology 26: 4350